News
A vaccine developed by the University of Oxford to protect people from a deadly virus has been granted support by Europe’s ...
GSK RSV vaccine Arexvy accepted for regulatory review by EMA to expand use in adults 18 years, older
London: GSK plc has announced that the European Medicines Agency (EMA) has accepted the company's regulatory application to ...
A vaccine developed by the University of Oxford to protect people from a deadly virus has been granted support by Europe’s medicines regulator.
Europe is increasingly grappling with illness and deaths from extreme weather and the arrival of tropical diseases but it has ...
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) is one of the 10 Best Small-Cap Growth Stocks to Buy According to Analysts. On June ...
Biju Dharmapalan As the world watches the International Space Station orbit above us, a historic mission awaits its moment to ...
The director of the Africa CDC believes the abrupt cutoff of Western aid will cause great suffering to Africans. At the same ...
There are many things happening in the Middle East at the moment but beneath them lies one single through-line: Israel is ...
Under Dr. Geary's leadership, Ionis submitted over 50 investigational new drug applications to regulatory agencies and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results